Ergot and triptan overuse in Austria--an evaluation of clinical data and cost.

@article{Lampl2002ErgotAT,
  title={Ergot and triptan overuse in Austria--an evaluation of clinical data and cost.},
  author={Christian Lampl and Andrea Buzath and Kambiz Azarian Yazdi and P. S. S{\'a}ndor},
  journal={Cephalalgia : an international journal of headache},
  year={2002},
  volume={22 10},
  pages={807-11}
}
Austria is one of the countries, in which ergots are still the most commonly used acute anti-migraine drugs. Overuse and chronification is a clinical problem for ergots, but also for the recently developed triptans. In a retrospective study for the year 1999 we evaluated clinical data from all Austrian neurological hospitals including cost of withdrawal as well as the estimated cost for ergots and triptans on the pharmaceutical retail market. We identified a total of 96 patients that underwent… CONTINUE READING

From This Paper

Figures, tables, results, connections, and topics extracted from this paper.
2 Extracted Citations
0 Extracted References
Similar Papers

Citing Papers

Publications influenced by this paper.

Similar Papers

Loading similar papers…